Trial Profile
Bariatric Surgery and Pharmacokinetics Lisdexamphetamine: BAR-MEDS Lisdexamphetamine
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder; Eating disorders; Mood disorders
- Focus Pharmacokinetics
- Acronyms BAR-MEDS Lisdexamphetamine
- 17 Apr 2018 New trial record